109 related articles for article (PubMed ID: 27916360)
1. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
[TBL] [Abstract][Full Text] [Related]
2. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.
Abdalla EK; Vauthey JN; Ellis LM; Ellis V; Pollock R; Broglio KR; Hess K; Curley SA
Ann Surg; 2004 Jun; 239(6):818-25; discussion 825-7. PubMed ID: 15166961
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC
World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402
[TBL] [Abstract][Full Text] [Related]
5. The long-term efficacy of imatinib with hepatic resection or other local treatment for gastrointestinal stromal tumours liver metastases: a retrospective cohort study.
Wen H; Huang Y; Huang S; Xiao H; Xie W; Zhou Q; Tan L; Ding Y; Liu X; Yu Y; Song Z; Shen S; Chen Z; Zhang X
Int J Surg; 2024 Apr; 110(4):2151-2161. PubMed ID: 38619177
[TBL] [Abstract][Full Text] [Related]
6. Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases.
Evrard S; Poston G; Kissmeyer-Nielsen P; Diallo A; Desolneux G; Brouste V; Lalet C; Mortensen F; Stättner S; Fenwick S; Malik H; Konstantinidis I; DeMatteo R; D'Angelica M; Allen P; Jarnagin W; Mathoulin-Pelissier S; Fong Y
PLoS One; 2014; 9(12):e114404. PubMed ID: 25485541
[TBL] [Abstract][Full Text] [Related]
7. Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore.
Baldin P; Van den Eynde M; Mlecnik B; Bindea G; Beniuga G; Carrasco J; Haicheur N; Marliot F; Lafontaine L; Fredriksen T; Lanthier N; Hubert C; Navez B; Huyghe N; Pagès F; Jouret-Mourin A; Galon J; Komuta M
J Pathol Clin Res; 2021 Jan; 7(1):27-41. PubMed ID: 32902189
[TBL] [Abstract][Full Text] [Related]
8. Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases.
Yamashita S; Venkatesan AM; Mizuno T; Aloia TA; Chun YS; Lee JE; Vauthey JN; Conrad C
JAMA Surg; 2017 Oct; 152(10):e172986. PubMed ID: 28854316
[TBL] [Abstract][Full Text] [Related]
9. Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases.
Serenari M; Ratti F; Stocco A; De Cobelli F; Serra C; Santangelo D; Fallani G; Della Corte A; Marino R; Ravaioli M; Aldrighetti L; Cescon M
Surg Endosc; 2024 May; 38(5):2611-2621. PubMed ID: 38499784
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the efficacy of different surgical strategies in the treatment of patients with initially resectable gastric cancer liver metastases].
Li L; Gao YH; Zang L; Xue K; Ke B; Shang L; Tang ZQ; Yu J; Liang YR; He ZR; Zheng HL; Huang H; Xiong JP; He ZY; Li JY; Lu TT; Song QY; Liu SH; Chen YW; Tang Y; Liang H; Qiao Z; Chen L
Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):370-378. PubMed ID: 38548604
[No Abstract] [Full Text] [Related]
11. Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.
Yamashita S; Brudvik KW; Kopetz SE; Maru D; Clarke CN; Passot G; Conrad C; Chun YS; Aloia TA; Vauthey JN
Ann Surg; 2018 Mar; 267(3):514-520. PubMed ID: 28002060
[TBL] [Abstract][Full Text] [Related]
12. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran.
Pourfaraji SM; Moghadam MN; Moradi AM; Shirmard FO; Mohammadzadeh N; Jafarian A
BMC Surg; 2024 May; 24(1):131. PubMed ID: 38702645
[TBL] [Abstract][Full Text] [Related]
14. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
[TBL] [Abstract][Full Text] [Related]
15. Liver resection and ablation for metastatic melanoma: A single center experience.
Doussot A; Nardin C; Takaki H; Litchman TD; D'Angelica MI; Jarnagin WR; Postow MA; Erinjeri JP; Kingham TP
J Surg Oncol; 2015 Jun; 111(8):962-8. PubMed ID: 26073980
[TBL] [Abstract][Full Text] [Related]
16. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
Turley RS; Peng PD; Reddy SK; Barbas AS; Geller DA; Marsh JW; Tsung A; Pawlik TM; Clary BM
Cancer; 2012 Jul; 118(14):3571-8. PubMed ID: 22086856
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer.
Lawes D; Chopada A; Gillams A; Lees W; Taylor I
Ann R Coll Surg Engl; 2006 Nov; 88(7):639-42. PubMed ID: 17132311
[TBL] [Abstract][Full Text] [Related]
18. Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis.
Mayo SC; Heckman JE; Shore AD; Nathan H; Parikh AA; Bridges JF; Anders RA; Anaya DA; Becker NS; Pawlik TM
Surgery; 2011 Aug; 150(2):204-16. PubMed ID: 21801959
[TBL] [Abstract][Full Text] [Related]
19. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.
Shady W; Petre EN; Vakiani E; Ziv E; Gonen M; Brown KT; Kemeny NE; Solomon SB; Solit DB; Sofocleous CT
Oncotarget; 2017 Sep; 8(39):66117-66127. PubMed ID: 29029497
[TBL] [Abstract][Full Text] [Related]
20. ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical Resection.
Torén W; Sasor A; Ansari D; Andersson R
Anticancer Res; 2024 Jun; 44(6):2597-2604. PubMed ID: 38821620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]